The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Laboratory cultures found group B strep, which can have serious consequences for newborns, including blood and lung infections. Women are supposed to be screened for strep at the end of pregnancy ...